Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
58.92
+0.79 (1.36%)
At close: Sep 21, 2026, 4:00 PM EDT
59.40
+0.48 (0.81%)
Pre-market: Sep 22, 2026, 5:04 AM EDT
Vaxcyte Employees
Vaxcyte had 507 employees as of December 31, 2025. The number of employees increased by 93 or 22.46% compared to the previous year.
Employees
507
Change (1Y)
93
Growth (1Y)
22.46%
Revenue / Employee
n/a
Profits / Employee
-$2,099,134
Market Cap
8.77B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 507 | 93 | 22.46% |
| Dec 31, 2024 | 414 | 160 | 62.99% |
| Dec 31, 2023 | 254 | 96 | 60.76% |
| Dec 31, 2022 | 158 | 69 | 77.53% |
| Dec 31, 2021 | 89 | 31 | 53.45% |
| Dec 31, 2020 | 58 | 15 | 34.88% |
| Dec 31, 2019 | 43 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Caris Life Sciences | 1,846 |
| Arrowhead Pharmaceuticals | 711 |
| ImmunityBio | 691 |
| Cytokinetics | 673 |
| TG Therapeutics | 399 |
| Immunovant | 315 |
| Kymera Therapeutics | 273 |
| Praxis Precision Medicines | 168 |
PCVX News
- 12 days ago - Vaxcyte Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 13 days ago - Vaxcyte Transcript: Wells Fargo 21st Annual Healthcare Conference - Transcripts
- 18 days ago - Vaxcyte names Luis Jodar chief medical officer, David McAvoy chief legal officer - TheFly
- 18 days ago - Vaxcyte narrows previously communicated VAX-31 guidance - TheFly
- 18 days ago - Vaxcyte Appoints Chief Medical Officer and Chief Legal Officer; Narrows Guidance for Expected VAX-31 OPUS-1 Topline Data - GlobeNewsWire
- 19 days ago - Vaxcyte Slides: Corporate presentation - Filings
- 25 days ago - Vaxcyte to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 6 weeks ago - Vaxcyte reports Q2 EPS ($1.97), consensus ($2.10) - TheFly